Print This Page

This page lists current other NCI and NIH cancer imaging initiatives, including grant mechanisms where industry is encouraged to apply.

For information about the funding process, go to Mechanisms or Guidelines.

The NCI's Division of Extramural Activities provides information about newly approved concepts, which may become RFAs and PAs. Check the Concepts Cleared at the NCI Board of Scientific Advisors Meeting web site for the earliest possible information about future initiatives.

• Revisions for Early-Stage Development of Informatics Technology (P01)

  • Release Date: September 20, 2012
  • Application Receipt Date: January 22, 2013, June 18, 2013, November 18, 2013, June 18, 2014, November 18, 2014, June 18, 2015.
  • Expiration Date: June 19, 2015
  • Contacts:

    Jiayin (Jerry) Li, M.D., Ph.D.; Phone: 301-435-5226; Email: jerry.li@nih.gov

    For contact information for specific areas, please consult the FOA for the complete list.

  The purpose of this Funding Opportunity Announcement (FOA) is to invite revisions (formerly called "competing revisions") from currently funded NCI P01 program projects for early-stage development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Initiative, this FOA aims to promote interdisciplinary collaboration in the development of innovative computational methods and informatics approaches that are essential for cancer research on all fronts to accelerate scientific discovery and ultimately translate data into knowledge and clinical practice. Applications that focus on data processing and analysis or mathematical/statistical modeling alone without new technology development are not appropriate for this FOA. 

• Advanced Development of Informatics Technology (U24)

  • Release Date: September 20, 2012
  • Application Receipt Date: January 22, 2013, June 18, 2013, November 18, 2013, June 18, 2014, November 18, 2014, June 18, 2015
  • Expiration Date: June 19, 2015
  • Contacts:

    Jiayin (Jerry) Li, M.D., Ph.D.; Phone: 301-435-5226; Email: jerry.li@nih.gov

    For contact information for specific areas, please consult the FOA for the complete list.

  The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge in cancer research. An emerging informatics technology is defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. If successful, these technologies would accelerate research in cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. This FOA is one component of the NCI's Informatics Technology for Cancer Research (ITCR) Initiative whose central mission is to promote research-driven informatics technology development.  Potential applicants who are interested in early-stage development should consult companion FOAs listed on the previous page.  Applications that focus on informatics data processing and analysis or mathematical/statistical modeling alone without informatics technology development are not appropriate for this FOA.

• Early-Stage Development of Informatics Technology (U01)

  • Release Date: September 20, 2012
  • Application Receipt Date: January 22, 2013, June 18, 2013, November 18, 2013, June 18, 2014, November 18, 2014, June 18, 2015 , by 5:00 PM local time of applicant organization.
  • Expiration Date: June 19, 2015
  • Contacts:

    Jiayin (Jerry) Li, M.D., Ph.D.; Phone: 301-435-5226; Email: jerry.li@nih.gov

    For contact information for specific areas, please consult the FOA for the complete list.

  The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U01) applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge in cancer research. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Initiative, this FOA focuses on early-stage development from prototyping to hardening and adaptation. The central mission of the ITCR is to promote research-driven informatics technology development. In order to be successful, proposed development plans must have a clear rationale on why the proposed technology is needed and how it will benefit the cancer research community. In addition, mechanisms to solicit feedback from users and collaborators throughout the development process should be included. Applications that focus on data processing and analysis or mathematical/statistical modeling alone without new technology development are not appropriate for this FOA.

  Earliest submission date: December 22, 2012

• Revisions for Early-Stage Development of Informatics Technology (U01)

  • Release Date: September 20, 2012
  • Application Receipt Date: January 22, 2013, June 18, 2013, November 18, 2013, June 18, 2014, November 18, 2014, June 18, 2015, by 5:00 PM local time of applicant organization.
  • Expiration Date: June 19, 2015
  • Contacts:

    Jiayin (Jerry) Li, M.D., Ph.D.; Phone: 301-435-5226; Email: jerry.li@nih.gov

    For contact information for specific areas, please consult the FOA for the complete list.

  The purpose of this Funding Opportunity Announcement (FOA) is to invite revisions (formerly called "competing revisions") from currently funded NCI U01 cooperative agreement projects for early-stage development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Initiative, this FOA aims to promote interdisciplinary collaboration in the development of innovative computational methods and informatics approaches that are essential for cancer research on all fronts to accelerate scientific discovery and ultimately translate data into knowledge and clinical practice. Applications that focus on data processing and analysis or mathematical/statistical modeling alone without new technology development are not appropriate for this FOA.

  Earliest submission date: December 22, 2012

• Revisions for Early-Stage Development of Informatics Technology (R01)

  • Release Date: September 20, 2012
  • Application Receipt Date: January 22, 2013, June 18, 2013, November 18, 2013, June 18, 2014, November 18, 2014, June 18, 2015, by 5:00 PM local time of applicant organization.
  • Expiration Date: June 19, 2015
  • Contacts:

    Jiayin (Jerry) Li, M.D., Ph.D.; Phone: 301-435-5226; Email: jerry.li@nih.gov

    For contact information for specific areas, please consult the FOA for the complete list.

  The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called "competing revisions") from currently funded NCI R01 and R37 (MERIT) research projects for early-stage development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Initiative, this FOA aims to promote interdisciplinary collaboration in the development of innovative computational methods and informatics approaches that are essential for cancer research on all fronts to accelerate scientific discovery and ultimately translate data into knowledge and clinical practice. Applications that focus on data processing and analysis or mathematical/statistical modeling alone without new technology development are not appropriate for this FOA.

  Earliest submission date: December 22, 2012

• PAR-12-145: NCI Exploratory/Developmental Research Grant Program (NCI Omnibus R21)

  • Release Date: March 29, 2012
  • Application Receipt Date: Earliest submission date May 16, 2012.
  • Expiration Date: September 8, 2015
  • Contacts:

    For this FOA, please see http://www.cancer.gov/researchandfunding/contacts for Scientific/Research Contacts at NCI.

  Purpose: The National Cancer Institute (NCI) Exploratory/Developmental Grant (R21) funding opportunity supports the development of new research activities in all areas of cancer research. The R21 mechanism is intended to encourage exploratory and developmental research projects by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (biomedical, behavioral, or clinical).

• CONTINUED DEVELOPMENT AND MAINTENANCE OF SOFTWARE (R01) (MULTIPLE IC'S) (PAR-11-028)

  • Release Date: November 12, 2010
  • Application Receipt Date: Standard dates apply
  • Expiration Date: January 8, 2014
  • Contacts:

    Jerry Li, Ph.D.; Tel. 301-435-5226; E-mail: jiayinli@mail.nih.gov

  • Letter of Intent Receipt Date: Not applicable

  This Funding Opportunity Announcement is aimed at satisfying one of the needs created by the parallel achievements and increased interdependence of the biological and computing sciences. This interdependence offers an unprecedented opportunity for sophisticated approaches to computer-enabled research in the biological, clinical, and behavioral sciences. The purpose of this program announcement is to assure the availability and continued usefulness of existing biomedical informatics/computational biology software. This program announcement is meant for existing software that serves a biological, clinical, or behavioral community of users. Applications under this program announcement can seek support to improve the existing software in several different ways listed below. Any of these improvements should benefit the existing user community and/or have high potential for attracting significantly more users.

  See full description in NIH Guide: PAR-11-028.

• PAR-10-234: Bioengineering Research Partnerships (BRP) [R01] (Multiple ICs)

  • Release Date: July 27, 2010
  • Application Receipt Date: Standard dates
  • Expiration Date: September 8, 2013
  • Contacts:

    Albert Lee, Ph.D., NIBIB, Phone: 301-451-4781, Email: alee@mail.nih.gov

  Participating Institutes and Centers (ICs) of the NIH invite applications for R01 awards to support Bioengineering Research Partnerships (BRPs) for basic, applied, and translational multi-disciplinary research that addresses important biological, clinical, or biomedical research problems. In the context of this program, a partnership is a multi-disciplinary research team that applies an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior.

  See full description in NIH Guide: PAR-10-234

• DEVELOPMENT OF ASSAYS FOR HIGH-THROUGHPUT DRUG SCREENING (NIDDK, NCI, NIAID, NIMH) (R01) (PA-10-213)

  • Release Date: June 10, 2010
  • Application Receipt Date: Standard Dates
  • Expiration Date: September 8, 2013
  • Contacts:

    Robert G Lees, Ph.D., NCI, Phone: 301-496-8783, Email: leesro@mail.nih.gov

  The purpose of this FOA is to stimulate the development of assays for high throughput screening (HTS) relevant to processes and diseases specific to the mission of the institutes involved, with the intent of using the assays to screen for small molecule compounds that show desired properties as probes for use in advancing knowledge about the relevant target, identifying new targets, or serving as pre-therapeutic leads.

  NCI:Assays pertinent to the mission of NCI should be justified in the application as relevant to cancer. The NCI is interested in development of assays to identify or evaluate small molecules for use in elucidating molecular, cellular, or in vivo mechanisms or processes of probable or known importance to cancer biology, and for use in developing strategies for cancer prevention, diagnosis, treatment or clinical monitoring of treatment. Assays proposed may be biochemical, cellular or model organism-based, and may be useful for discovering small molecule probes, preventive or therapeutic drug leads, or imaging agent leads. Applicants may find the NCI Developmental Therapeutics Program () resources to be helpful. Collaborations between laboratories with screen development capabilities and laboratories with small molecule synthesis capabilities are encouraged.

  See full description in NIH Guide: PA-10-213

• Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Postdoctoral Fellows (F32) (PA-10-110)

  • Release Date: February 16, 2010
  • Application Receipt Date: Standard dates apply
  • Expiration Date: January 8, 2013
  • Contacts:

    http://grants.nih.gov/grants/guide/contacts/parent_F32.html

  The objective of NIH-supported Ruth L. Kirschstein National Research Service Awards programs is to help ensure that a diverse pool of highly trained scientists are available in adequate numbers and in appropriate research areas to address the Nation's biomedical, behavioral, and clinical research needs.

  The purpose of the postdoctoral fellowship (F32) award is to provide support to promising postdoctoral applicants who have the potential to become productive and successful independent research investigators. The proposed postdoctoral training must offer an opportunity to enhance the applicant's understanding of the health-related sciences, and must be within the broad scope of biomedical, behavioral, or clinical research or other specific disciplines relevant to the research mission of the participating NIH Institutes and Centers. Applicants with a health professional doctoral degree may use the proposed postdoctoral training to satisfy a portion of the degree requirements for a master's degree, a research doctoral degree or any other advanced research degree program.

  The NRSA legislation requires that the Nation's overall needs for biomedical research personnel be taken into account by giving special consideration to physicians and other health professionals who propose to become active biomedical researchers and who agree to undertake a minimum of 2 years of biomedical, behavioral or clinical research. Individuals from diverse racial and ethnic groups and individuals with disabilities and individuals from disadvantaged backgrounds are always encouraged to apply for NIH support.

  Each NIH Institute and Center (IC) has a unique scientific purview and different program goals and initiatives that evolve over time. Prospective Fellowship Applicants are encouraged to contact the relevant NIH staff for IC-specific programmatic information: Table of Institute and Center Contacts.

  URL: http://grants.nih.gov/grants/guide/pa-files/PA-10-110.html

• 1
• 2
• Next »